HomeTargets › mTOR

mTOR (1 companies · 5 programs)

Companies with an active program directed at mTOR.

Quoin Pharmaceuticals, Ltd. QNRX

  • rapamycin — Microcystic Lymphatic Malformations Preclinical
  • rapamycin — Venous Malformations Preclinical
  • rapamycin — Gorlin Syndrome Preclinical
  • rapamycin — Epidermolysis Bullosa Preclinical
  • rapamycin — Pachyonychia Congenita Preclinical